Skip to main content
Retour
Watch Compare

Bio Essence Corp

Qualité des données : 100%
BIOE
OTC Manufacturing Chemicals
0,40 €
▲ 0,15 € (60,00%)
Cap. Boursière: 9,50 M
Prix
0,25 €
Cap. Boursière
9,50 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Revenue grew 20,91% annually over 5 years — strong growth
Net margin of 47,23% shows strong profitability
Generating 1,57 M in free cash flow
P/E of 10,60 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 464,87%
Cash machine — converts 175,16% of earnings into free cash flow

Croissance

Revenue Growth (5Y)
20,91%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)485,78%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin47,23%
Op. Margin47,43%

Sécurité

Debt / Equity
N/A
Current Ratio0,06
Interest Coverage411,72

Valorisation

PE (TTM)
10,60
Au-dessus de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDA10,59
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E 10,6 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % 47,2 -41,5
Rev Growth 5Y % 20,9 1,8
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2026 — 2,29 M —

All Fundamental Metrics
Growth
Revenue Growth (1Y) 485,78% Revenue Growth (3Y) 85,49%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 20,91% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,90 M Net Income (TTM) 896 197,0
ROE N/A ROA 603,04%
Gross Margin 75,28% Operating Margin 47,43%
Net Margin 47,23% Free Cash Flow (TTM) 1,57 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,06
Interest Coverage 411,72 Asset Turnover 12,77
Working Capital -3,05 M Tangible Book Value -3,10 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 10,60 Forward P/E N/A
P/B Ratio N/A P/S Ratio 5,01
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 10,59 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 16,52%
Market Cap 9,50 M Enterprise Value 9,53 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0,05
FCF / Share 0,04 OCF / Share 0,04
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 175,16%
SBC-Adj. FCF N/A Growth Momentum 464,87

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,90 M 323 940,0 551 506,0 985 757,0 887 984,0
Net Income 896 197,0 -1,31 M -971 879,0 -809 679,0 -647 564,0
EPS (Diluted) — -0,03 -0,02 -0,02 —
Gross Profit 1,43 M 217 077,0 277 446,0 384 949,0 298 324,0
Operating Income 900 011,0 -459 438,0 -789 050,0 -782 804,0 -857 527,0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 235,0 911,0 17 418,0 53 977,0 35 802,0
Interest Expense 2 186,0 2 153,0 17 344,0 — 38 558,0
Income Tax 800,0 800,0 2 400,0 3 300,0 3 300,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 422 474,0 281 024,0 2,66 M 1,55 M 1,70 M
Total Liabilities 2,50 M 3,25 M 4,32 M 4,79 M 4,13 M
Shareholders' Equity -2,07 M -2,97 M -1,66 M -3,24 M -2,43 M
Total Debt 57 482,0 56 481,0 — — —
Cash & Equivalents — 1 371,0 114,0 6 262,0 303,0
Current Assets 422 377,0 280 692,0 1,10 M 203 831,0 261 962,0
Current Liabilities 2,44 M 2,80 M 3,18 M 3,56 M 2,76 M